Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 4/20 | 0.40 |
| ▸ | CES1 | P23141 | 4/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25277613 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25277664 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25277227 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25270412 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25226892 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25224031 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25271598 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25270460 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25272345 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 | |
| SCHEMBL25272099 | 0.98 | CA12 (0.50) | CA12CA1CA9CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1862198-B1 | Brightening and/or dyeing agent with urea derivatives | HENKEL AG & CO KGAA (DE) | 2017-04-05 | — | — | EP | claimed |
| EP-2108406-A1 | Anionic dyes and hair dye compositions containing them | DyStar Textilfarben GmbH & Co. Deutschland KG (DE) | 2009-10-14 | — | — | EP | claimed |
| WO-2008023383-A1 | NOVEL PROCESS FOR THE PREPARATION OF TELITHROMYCIN | ALEMBIC LIMITED (IN) | 2008-02-28 | — | — | WO | claimed |
| US-20080051352-A1 | Novel process for the preparation of telithromycin | ALEMBIC LIMITED (IN) | 2008-02-28 | — | — | US | claimed |
| EP-1505948-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2005-02-16 | — | — | EP | claimed |
| US-20030220300-A1 | Reduction of hair growth | GILLETTE COMPANY, THE | 2003-11-27 | — | — | US | claimed |
| WO-2003096997-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2003-11-27 | — | — | WO | claimed |
| EP-1115034-A1 | Use of N,N-dialkyl ureas in photoresist developers | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2001-07-11 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-113924334-B | Silane coupling agent composition comprising silane compound and protein denaturing agent, and rubber composition comprising same | 引能仕株式会社 | 2024-08-16 | — | — | CN | disclosed |
| CN-115720584-B | Silane coupling agent composition and rubber composition containing same | 引能仕株式会社 | 2024-08-02 | — | — | CN | disclosed |
| US-4873364-A | THERMAL DECOMPOSITION OF THE CORRESPONDING UREA IN THE PRESENCE OF A TERTIARY AMINE HYDROHALIDE | ARCO CHEMICAL TECHNOLOGY, INC. (US) | 1989-10-10 | — | — | US | disclosed |
| US-4871871-A | DECOMPOSING AROMATIC BISDIALKYL UREA WITH TERTIARY AMINE SALT PROMOTER IN SOLVENT | ARCO CHEMICAL TECHNOLOGY, INC. (US) | 1989-10-03 | — | — | US | disclosed |
| EP-0186297-B1 | PESTICIDAL BIPHENYLYLOXY AND BIPHENYLYLALKOXY ARYL ACYL UREA COMPOUNDS, A PROCESS FOR THEIR PREPARATION, PESTICIDAL COMPOSITIONS AND A METHOD OF CONTROLLING PESTS | RHONE-POULENC NEDERLAND B.V. (NL) | 1989-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051352-A1 | Novel process for the preparation of telithromycin | TREH, CYP3A7, CYP3A4 | CA12 4752/4885CA1 4876/4885CA9 3553/4885 |
| US-20030220300-A1 | Reduction of hair growth | FGF1, FGF2, MKI67 | CA12 3407/4885CA1 3741/4885CA9 3771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.